This month keep an eye out for the National Association of Insurance Commissioners recommendations to the Department of Health and Human Services on how health insurers might calculate their MLRs to satisfy the new regulations.
The new rules under the Patient Protection and Affordable Care Act that regulate your medical loss ratio (MLR) allow the inclusion of quality initiatives when adding up your care costs. While that establishes one compliance detail, it also brings up questions about several others, such as, what does the law consider a quality initiative?
This month, keep an eye out for the National Association of Insurance Commissioners (NAIC) recommendations to the Department of Health and Human Services on how health insurers might calculate their MLRs to satisfy the new regulations. The law specifically calls for a minimum 85% MLR for large group markets and 80% for small group and individual markets but doesn't define what constitutes each of those. NAIC will offer definitions soon.
"This is a paradigm shift for accounting and reporting of the healthcare business," Litwinski says.
Historically, health plans might have calculated MLRs on a regional basis, but she predicts the final guidance will require state-by-state calculations reported to the federal government.
"Thirty-four states have some guidelines for MLR but it appears this will preempt the calculations that have historically been made," she says. "We're moving to a federal calculation of MLR."
NAIC SAFEGUARDS SOLVENCY
You might be concerned that federal involvement in how incoming premium dollars can be spent will essentially normalize plans' profitability. In the past, one bucket of business with low profitability could be offset by another, more profitable bucket of business. Not so anymore. Losses, low profits and modest profits will keep you under the MLR ceiling, but higher profits will have to be given back to members as rebates.
As a result of the rebate provision, some small plans or business lines could be in danger of shutting down altogether. Litwinski says that reality isn't being ignored.
"Solvency has been discussed, and they are aware of the possibility," she says. "NAIC is diligently looking at some safeguards as part of the MLR to prevent that from happening."
NAIC truly has its hands full. There's a long list of MLR-calculation questions that its committees are trying to answer, such as the definition of a "plan year" as it relates to reporting and rebate requirements and how common statistical fluctuations should be considered. Currently, the statistical credibility of a bucket of Medicare-supplement business is considered in that market's refund formula, so there's hope.
Litwinski says she's optimistic about the new healthcare marketplace, and that it's not too late for you to speak up about MLRs.
"The most important aspects of the MLR calculation will be to provide input now to regulators and HHS on quality-improvement costs," she says. "It's still a fluid process at this point."
Julie Miller is editor-in-chief of MANAGED HEALTHCARE EXECUTIVE. She can be reached at julie.miller@advanstar.com
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More
2 Commerce Drive
Cranbury, NJ 08512